Join our Presentation on Day 2
‘EMA Mutamind Study and Prediction of Nitrosamine Metabolism‘
Presented by Kevin Cross, Director of Insilico Science and Business Development
Part of the symposium: “Nitrosamine Safety Assessment”
Thursday 7 May
For more information, visit the Event Website
